![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/166 | |
A61K 31/353 | |||
A61K 31/404 | |||
A61K 31/4184 | |||
A61K 31/4412 | |||
A61K 31/506 | |||
A61K 31/517 | |||
A61K 45/06 | |||
A61P 35/00 | |||
A61P 17/00 |
(11) | Number of the document | 2211849 |
(13) | Kind of document | T |
(96) | European patent application number | 08837957.3 |
Date of filing the European patent application | 2008-10-10 | |
(97) | Date of publication of the European application | 2010-08-04 |
(45) | Date of publication and mention of the grant of the patent | 2013-07-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2008/003415 |
Date | 2008-10-10 |
(87) | Number | WO 2009/047505 |
Date | 2009-04-16 |
(30) | Number | Date | Country code |
0719771 | 2007-10-10 | GB |
(72) |
YOUNG, Malcolm, Philip, GB
THOMAS, Catherine, Mary, GB
IDOWU, Olusola, Clement, GB
CHARLTON, Julie Anne, GB
|
(73) |
E-Therapeutics plc,
17 Blenheim Office Park, Long Hanborough Oxfordshire OX29 8LN,
GB
|
(54) | Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma. |
Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma. |